Fenofibrate May Reduce CVD in Statin-Treated T2DM Patients
Fenofibrate therapy may reduce cardiovascular disease (CVD) in statin-treated patients with diabetes and dyslipidemia, according to a study published online in JAMA Cardiology.

"The continued observation of heterogeneity of treatment response by baseline lipids suggests that fenofibrate therapy may reduce CVD in patients with diabetes with hypertriglyceridemia and low high-density lipoprotein cholesterol," the authors write.

http://www.renalandurologynews.com/diabetes/statin-treated-type-2-diabetes-fenofibrate-may-reduce-cvd-risk/article/629530/
Like
Comment
Share